telavancin and Mediastinitis

telavancin has been researched along with Mediastinitis* in 1 studies

Other Studies

1 other study(ies) available for telavancin and Mediastinitis

Article	Year
Heart transplantation in a patient with heteroresistant vancomycin-intermediate Staphylococcus aureus ventricular assist device mediastinitis and bacteremia. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:5 Vancomycin-intermediate Staphylococcus aureus (VISA) infections are an emerging problem and antibiotic options are limited. We report the first case, to our knowledge, of heteroresistant VISA mediastinitis and bacteremia in a patient with a ventricular assist device who underwent orthotopic heart transplantation with clinical cure. Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Debridement; Defibrillators, Implantable; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipoglycopeptides; Mediastinitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance	2013

Article

Year

Heart transplantation in a patient with heteroresistant vancomycin-intermediate Staphylococcus aureus ventricular assist device mediastinitis and bacteremia.

Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:5

Vancomycin-intermediate Staphylococcus aureus (VISA) infections are an emerging problem and antibiotic options are limited. We report the first case, to our knowledge, of heteroresistant VISA mediastinitis and bacteremia in a patient with a ventricular assist device who underwent orthotopic heart transplantation with clinical cure.

Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Debridement; Defibrillators, Implantable; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipoglycopeptides; Mediastinitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance

2013